# Acne FDA approvals and PDUFA dates

Canonical: https://sec-api.dev/indications/acne

> 2 upcoming FDA catalysts in acne: acne mrna (messenger ribonucleic acid) vaccine (SNY) on Jul to Oct 2028 (topline data readout); acne mrna (messenger ribonucleic acid) vaccine (SNY) on July 2028 (primary completion).

Data as of November 16, 2026 (snapshot 20261116T222116Z). Every date quotes the SEC filing or FDA page it came from. Date precision: quarter only, month only.

**Free:** every drug page and the next 30 days of the FDA calendar, no account. Calendar API, alerts when a date moves, and full history: https://sec-api.dev/pricing . Free API key: https://sec-api.dev/sign-up?ref=ai-claudebot

## Catalysts

| Date | Event | Ticker | Indication | Status | Source sentence |
| --- | --- | --- | --- | --- | --- |
| Jul to Oct 2028 | [Acne mrna (messenger ribonucleic acid) vaccine topline data readout](https://sec-api.dev/pdufa/acne-mrna-messenger-ribonucleic-acid-vaccine) | SNY | Acne | scheduled | "NCT07756957 (Safety of the Acne mRNA Vaccine in Adolescents 12 to 17 Years of Age With Moderate to Severe Acne): Overall Status NOT_YET_RECRUITING; Phase PHASE2; Primary Completion 2028-07-19 (ESTIMATED); Lead Sponsor Sanofi." ([ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT07756957)) |
| July 2028 | [Acne mrna (messenger ribonucleic acid) vaccine primary completion](https://sec-api.dev/pdufa/acne-mrna-messenger-ribonucleic-acid-vaccine) | SNY | Acne | scheduled | "NCT07756957 (Safety of the Acne mRNA Vaccine in Adolescents 12 to 17 Years of Age With Moderate to Severe Acne): Overall Status NOT_YET_RECRUITING; Phase PHASE2; Primary Completion 2028-07-19 (ESTIMATED); Lead Sponsor Sanofi." ([ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT07756957)) |

## Drugs

- [Acne mrna (messenger ribonucleic acid) vaccine](https://sec-api.dev/pdufa/acne-mrna-messenger-ribonucleic-acid-vaccine) (SNY)

## Feeds and downloads

- Subscribe (iCal): https://sec-api.dev/indications/acne.ics
- Next 30 days as CSV: https://sec-api.dev/fda-calendar.csv . JSON: https://sec-api.dev/fda-calendar.json . All events (iCal): https://sec-api.dev/fda-calendar.ics
- New or moved PDUFA dates: https://sec-api.dev/pdufa-dates/feed.xml (RSS), https://sec-api.dev/pdufa-dates/feed.json (JSON Feed)
- FDA approvals: https://sec-api.dev/fda-approvals-today/feed.xml (RSS), https://sec-api.dev/fda-approvals-today/feed.json (JSON Feed)
- License: CC BY 4.0 for the public 30-day window (https://sec-api.dev/biotech/license.txt). Full history: https://sec-api.dev/pricing

## Cite this page

sec-api.dev. "Acne FDA approvals and PDUFA dates." Biotech catalyst calendar, data as of November 16, 2026 (snapshot 20261116T222116Z). https://sec-api.dev/indications/acne

```bibtex
@misc{secapidev_indications_acne_20261116,
  title        = {Acne FDA approvals and PDUFA dates},
  author       = {{sec-api.dev}},
  year         = {2026},
  month        = {nov},
  howpublished = {\url{https://sec-api.dev/indications/acne}},
  note         = {Biotech catalyst calendar, data as of 2026-11-16, snapshot 20261116T222116Z. Compiled from SEC EDGAR filings, FDA and ClinicalTrials.gov; each date quotes its source.}
}
```

```json
{"type":"dataset","id":"secapidev_indications_acne_20261116","title":"Acne FDA approvals and PDUFA dates","publisher":"sec-api.dev","URL":"https://sec-api.dev/indications/acne","issued":{"date-parts":[[2026,11,16]]},"version":"20261116T222116Z","license":"https://creativecommons.org/licenses/by/4.0/","note":"Compiled from SEC EDGAR filings, FDA and ClinicalTrials.gov; each date quotes its source."}
```

---
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Food and Drug Administration or the U.S. Securities and Exchange Commission. Dates are as stated by sponsors and FDA; the FDA can act before or after a target date. Not investment advice.
